SMC4 and acute lymphoblastic leukemia: Clinical research also demonstrated that the expression of SMC4 was associated with various clinical outcomes in pediatric patients with ALL; the high SMC4 expression group had a worse disease-specific survival rate and poorer overall survival rate (40).